In 2007 the UK's National Audit Office reported that Primary Care Trusts could save more than GBP200.0 million ($305.8 million) a year without compromising patient care if general practitioners prescribed cheaper, generic drugs. Keele University has now confirmed the NAO's finding by calculating that almost GBP400.0 million has been saved by the Department of Health, the National Health Service and PCTs in England, through more cost-effective prescribing as recommended in the NAO report.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze